We validated the reverse expression and prognostic value of METTL3 and METTL14 in HCC and discovered that most of the mRNAs and associated signaling pathways and biological processes regulated by METTL3 and METTL14 are different, which may be partly responsible for their contrary functions in HCC. The gene discussed is METTL3; the disease is hepatocellular carcinoma.